On Tuesday, Pfizer Inc (NYSE: PFE) was 1.48% up from the session before settling in for the closing price of $25.08. A 52-week range for PFE has been $20.92 – $27.69.
Annual sales at Healthcare sector company slipped by -13.27% over the past five years. When this article was written, the company’s average yearly earnings per share was at 0.57%. With a float of $5.68 billion, this company’s outstanding shares have now reached $5.69 billion.
Pfizer Inc (PFE) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Pfizer Inc stocks. The insider ownership of Pfizer Inc is 0.12%, while institutional ownership is 66.69%. The most recent insider transaction that took place on May 23 ’25, was worth 1,380,632. Before that another transaction happened on May 05 ’25, when Company’s Former Officer proposed sale 55,000 for $23.87, making the entire transaction worth $1,312,736.
Pfizer Inc (PFE) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted 0.63 earnings per share (EPS) during the time that was better than consensus figure (set at 0.46) by 0.17. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.79 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.57% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -1.12% during the next five years compared to -13.27% drop over the previous five years of trading.
Pfizer Inc (NYSE: PFE) Trading Performance Indicators
You can see what Pfizer Inc (PFE) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.97. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.30. Likewise, its price to free cash flow for the trailing twelve months is 13.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.72, a number that is poised to hit 0.60 in the next quarter and is forecasted to reach 3.11 in one year’s time.
Technical Analysis of Pfizer Inc (PFE)
Pfizer Inc (NYSE: PFE) saw its 5-day average volume 94.03 million, a positive change from its year-to-date volume of 51.44 million. As of the previous 9 days, the stock’s Stochastic %D was 50.16%.
During the past 100 days, Pfizer Inc’s (PFE) raw stochastic average was set at 51.09%, which indicates a significant decrease from 60.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.68 in the past 14 days, which was higher than the 0.51 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $24.82, while its 200-day Moving Average is $24.58. Nevertheless, the first resistance level for the watch stands at $25.65 in the near term. At $25.84, the stock is likely to face the second major resistance level. The third major resistance level sits at $26.18. If the price goes on to break the first support level at $25.12, it is likely to go to the next support level at $24.78. The third support level lies at $24.59 if the price breaches the second support level.
Pfizer Inc (NYSE: PFE) Key Stats
There are 5,685,708K outstanding shares of the company, which has a market capitalization of 144.70 billion. As of now, sales total 63,627 M while income totals 8,031 M. Its latest quarter income was 16,654 M while its last quarter net income were 3,541 M.
